Delivery Order SPE2DB25D3404-SPE2DB25FUMNJ

Award Date 3/17/25
Potential Completion Date 3/18/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,114.17 firm fixed-price delivery order contract covers the supply of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML medical products. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,851.81 firm fixed-price delivery order is for the supply of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML medical products. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,525.20 firm fixed-price delivery order is for the supply of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML medical products. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,438.70 firm fixed-price delivery order is for the supply of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML, a medical product. The contract has an ultimate completion date of February 19, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,663.96 firm fixed-price delivery order is for the supply of "ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML", a medical product. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,480.86 firm fixed-price delivery order is for the supply of pharmaceutical products, specifically ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The award is part of a larger $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,143.87 firm fixed-price delivery order is for the supply of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML, a medical product. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $4,407.19 firm fixed price delivery order contract covers the procurement of ZEPBOUND 15 MG/0.5 ML PEN 0.5ML pharmaceutical products. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,800.30 firm fixed-price delivery order is for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a medical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,051.63, is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total potential value of $999,999,999 and runs through November 2026. The contract covers the delivery of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML, a medical product, to support...
  • SPE2DB25D3404
    Indefinite Delivery Contract
  • SPE2DB25D3404-SPE2DB25FUMNJ
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,459.86 firm fixed-price delivery order is for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML pharmaceutical products to support military healthcare programs.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to the military. This IDC, which runs through November 2026, encompasses critical medical commodities across multiple therapeutic areas. The contract award did not have a set-aside designation, indicating open competition.

Generated 6/16/25, 10:48 AM